Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Ventricular Dysfunction, Left D018487 33 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Sclerosis D012598 5 associated lipids
Atherosclerosis D050197 85 associated lipids
beta-Thalassemia D017086 5 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Coronary Stenosis D023921 6 associated lipids
Bacteremia D016470 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Thromboangiitis Obliterans D013919 4 associated lipids
Menorrhagia D008595 4 associated lipids
Dyslipidemias D050171 7 associated lipids
Pregnancy Complications D011248 19 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Cat Diseases D002371 12 associated lipids
Ductus Arteriosus, Patent D004374 5 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Weight Loss D015431 56 associated lipids
Endotoxemia D019446 27 associated lipids
Tooth, Impacted D014095 9 associated lipids
Blister D001768 16 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Lupus Nephritis D008181 8 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Weil Disease D014895 2 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sneezing D012912 6 associated lipids
Helicobacter Infections D016481 21 associated lipids
Infertility D007246 3 associated lipids
Embolism, Fat D004620 4 associated lipids
Polycystic Kidney Diseases D007690 12 associated lipids
Heart Septal Defects D006343 2 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
Pneumonia, Viral D011024 3 associated lipids
Intermittent Claudication D007383 6 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Hydatidiform Mole D006828 3 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Low-dose aspirin in polycythaemia vera: a pilot study. Gruppo Italiano Studio Policitemia (GISP). 1997 Br. J. Haematol. pmid:9163613
Klosterhalfen B et al. The influence of heat shock protein 70 induction on hemodynamic variables in a porcine model of recurrent endotoxemia. 1997 Shock pmid:9165671
Oguogho A et al. Chloroquine minimizes sampling artefacts for radioimmunological determination of thromboxane B2 in plasma. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9175176
Barbieri B et al. p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner. 1997 Thromb. Res. pmid:9175234
Vila V et al. Fibrinopeptide A release from intraplatelet fibrinogen is related to thrombin platelet activation. 1997 Thromb. Res. pmid:9175247
Bräutigam R et al. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. 1997 Atherosclerosis pmid:9180250
Murthy S et al. Ischemia/reperfusion injury in the rat colon. 1997 Inflammation pmid:9187961
Oosaki R et al. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. 1997 Allergy pmid:9188934
Ali M et al. Synthesis of prostaglandin D2 and thromboxane B2 by human platelets. 1977 Thromb. Res. pmid:918907
Fujinishi A et al. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. 1997 Angiology pmid:9194537
Cook ME et al. Comparative effects of nabumetone, sulindac, and ibuprofen on renal function. 1997 J. Rheumatol. pmid:9195523
Hato T et al. Outside-in signaling from integrin alpha IIb beta 3 into platelets in the absence of agonist-induced signaling. 1997 Int. J. Hematol. pmid:9195778
Carty TJ et al. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. 1997 Inflamm. Res. pmid:9197987
Hellyer PW et al. Effect of NG-nitro-L-arginine-methyl-ester on cardiopulmonary function and biosynthesis of cyclooxygenase products during porcine endotoxemia. 1997 Crit. Care Med. pmid:9201060
Yan Y et al. [Study on mechanism of eye-signs in blood stasis syndrome]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9206243
Nanji AA et al. Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat. 1997 Hepatology pmid:9214456
Malini PL et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. 1997 Lancet pmid:9217714
Ansley DM et al. Platelet activating factor and thromboxane B2 production after cardiopulmonary bypass. 1997 May-Jun J Invest Surg pmid:9219083
Fenner H Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. 1997 Semin. Arthritis Rheum. pmid:9219317
De la Cruz JP et al. Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. 1997 Thromb. Res. pmid:9219331
Matsumata T et al. Urinary excretion of prostaglandins and renal function after hepatic resection. 1997 May-Jun Hepatogastroenterology pmid:9222688
Inui Y et al. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus. 1994 J. Atheroscler. Thromb. pmid:9222878
Hansen TN and Brockbank KG Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists. 1997 Transfusion pmid:9225932
Calzada C et al. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. 1997 Biochem. J. pmid:9230133
Desideri N et al. N-omega-carbethoxypentyl-4-quinolones: a new class of leukotriene biosynthesis inhibitors. 1997 Arch. Pharm. (Weinheim) pmid:9230527
Rautanen M et al. Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. 1997 Crit. Care Med. pmid:9233750
Davì G et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 1997 Circulation pmid:9236419
Johnson RD et al. Aspirin induces increased expression of both prostaglandin H synthase-1 and prostaglandin H synthase-2 in cultured human placental trophoblast. 1997 Am. J. Obstet. Gynecol. pmid:9240586
Szebeni J et al. Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1. 1997 Artif Cells Blood Substit Immobil Biotechnol pmid:9242930
González E et al. Influence of nitric oxide synthase and kinin antagonists on metabolic parameters in chronic streptozotocin-induced diabetes mellitus. 1997 Prostaglandins pmid:9247972
Kotuliaková K et al. Human polymorphonuclear leukocytes: effect of chloroquine on aggregation, arachidonic acid liberation and thromboxane B2 generation. 1996 Gen. Physiol. Biophys. pmid:9248834
Brinkmann A et al. The impact of prostanoids on pulmonary gas exchange during abdominal surgery with mesenteric traction. 1997 Anesth. Analg. pmid:9249099
Teng CM et al. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man. 1997 J. Pharm. Pharmacol. pmid:9255715
van Kooten F et al. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. 1997 Stroke pmid:9259748
Cenni E et al. CD62, thromboxane B2, and beta-thromboglobulin: a comparison between different markers of platelet activation after contact with biomaterials. 1997 J. Biomed. Mater. Res. pmid:9260099
Slepko N et al. Reorientation of prostanoid production accompanies "activation" of adult microglial cells in culture. 1997 J. Neurosci. Res. pmid:9260740
Hishinuma T et al. Microdetermination of the thromboxane B3 gas chromatography-selected-ion monitoring using [18O]thromboxane B3 as an internal standard. 1997 Prostaglandins pmid:9261859
Tulppala M et al. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. 1997 Hum. Reprod. pmid:9262298
Nanji AA et al. Alterations in thromboxane synthase and thromboxane A2 receptors in experimental alcoholic liver disease. 1997 J. Pharmacol. Exp. Ther. pmid:9262373
De La Cruz JP et al. Effects of S-adenosyl-L-methionine on platelet thromboxane and vascular prostacyclin. 1997 Biochem. Pharmacol. pmid:9264331
Serebruany VL et al. Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor? 1997 Mol. Aspects Med. pmid:9266521
Chang TS et al. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets. 1997 Biochem. Pharmacol. pmid:9271330
Azevedo I et al. Increased spontaneous release of tumour necrosis factor-alpha by alveolar macrophages from wheezy infants. 1997 Eur. Respir. J. pmid:9272917
Ku K et al. Influences of dietary omega-3 polyunsaturated fatty acids on the recovery of cardiac and renal functions after preservation in hyperlipidemic rats. 1997 Transplantation pmid:9275102
Xing X and Xia S [The injury of liver sinusoidal endothelial cells in a rat's isolated liver perfusion (ILP) model for regional chemotherapy]. 1996 Zhonghua Wai Ke Za Zhi pmid:9275689
Lewis K et al. Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung. 1997 Can. J. Physiol. Pharmacol. pmid:9276148
Berg J et al. Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6. 1997 J Pharmacol Toxicol Methods pmid:9279772
Freese R and Mutanen M Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. 1997 Am. J. Clin. Nutr. pmid:9280178
Santillan-Doherty P et al. Plasma thromboxane B2 concentrations and pulmonary vascular resistance during lung reperfusion. 1997 Jul-Aug J Invest Surg pmid:9284000
Cipollone F et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 1997 Circulation pmid:9286937
Trang LE et al. Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. 1977 Scand. J. Rheumatol. pmid:929121
Abate A et al. Inhibition of mediator release from anaphylactic guinea pig hearts by the novel phospholipase A2 inhibitor 3-(4-octadecylbenzoyl) acrylic acid. 1997 Inflamm. Res. pmid:9297549
Tanaka M et al. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats. 1997 Biol. Neonate pmid:9303217
Berlin I et al. [Comparison between effects of morning and evening administration of effervescent calcium carbasalate (equivalent of 160 mg aspirin) on the gastroduodenal mucosa in healthy volunteers]. 1997 Pathol. Biol. pmid:9309270
Swails WS et al. Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. 1997 Sep-Oct JPEN J Parenter Enteral Nutr pmid:9323688
Uteshev DB and Uteshev BS [Adhesive molecules as drugs and objects of pharmacological effect in myocardial ischemia and reperfusion]. 1997 May-Jun Eksp Klin Farmakol pmid:9324410
Moser L et al. ACE inhibitor effects on platelet function in stages I-II hypertension. 1997 J. Cardiovasc. Pharmacol. pmid:9335405
Matrougui K et al. Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. 1997 Hypertension pmid:9336397
Hashimoto Y et al. Characteristics of protein kinase C-independent exocytosis in human platelets. 1997 Thromb. Res. pmid:9336873
Chavali SR et al. Decreased production of interleukin-1-beta, prostaglandin-E2 and thromboxane-B2, and elevated levels of interleukin-6 and -10 are associated with increased survival during endotoxic shock in mice consuming diets enriched with sesame seed oil supplemented with Quil-A saponin. 1997 Int. Arch. Allergy Immunol. pmid:9338609
Zahavi M and Zahavi J Concomitant in vitro platelet hypofunction and increased thromboxane B2 (TXB2) generation and enhanced in vivo platelet activation. A distinct syndrome in thrombosis? 1997 Eur. J. Haematol. pmid:9338626
Supanz S et al. Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat. 1997 Arzneimittelforschung pmid:9342416
Neupert W et al. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. 1997 Br. J. Pharmacol. pmid:9351505
Lahoz C et al. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. 1997 Eur. J. Clin. Invest. pmid:9352251
Baskett A et al. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. 1997 Am. J. Vet. Res. pmid:9361895
Barton MH et al. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. 1997 Am. J. Vet. Res. pmid:9361896
Chen L et al. Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. 1997 Am. J. Physiol. pmid:9362253
Bar J et al. The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. 1997 Thromb. Haemost. pmid:9364994
Walker JS et al. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". 1997 Arthritis Rheum. pmid:9365082
Riendeau D et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. 1997 Can. J. Physiol. Pharmacol. pmid:9365818
John H and Schlegel W Reversed-phase high-performance liquid chromatographic method for the determination of the 11-hydroxythromboxane B2 anomers equilibrium. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9367188
Capponi A et al. Indomethacin modifies the fetal hemodynamic response induced by percutaneous umbilical blood sampling. 1997 Am. J. Obstet. Gynecol. pmid:9369815
Siler-Khodr TM et al. The effect of dexamethasone on CRH and prostanoid production from human term placenta. 1997 Prostaglandins pmid:9373879
Farker K et al. Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. 1997 Prostaglandins pmid:9373880
Savla U et al. Cyclic stretch of airway epithelium inhibits prostanoid synthesis. 1997 Am. J. Physiol. pmid:9374729
Kobayashi T et al. Changes in platelet calcium concentration by thromboxane A2 stimulation in patients with nephrotic syndrome of childhood. 1997 Nephron pmid:9375825
Nygaard OP et al. The inflammatory properties of contained and noncontained lumbar disc herniation. 1997 Spine pmid:9383853
Xiao X et al. Effect of captopril on renal hemodynamics and renal prostaglandins in early type II diabetic patients with normo-or microalbuminuria. 1996 Chin. Med. Sci. J. pmid:9387403
Sang Y et al. [Effects of tangshenkang capsule on diabetic nephropathy]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9387731
Han JA and Hu WY [Progress in the study on protective effect of saponins Panax notoginseng on ischemic brain damage]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9387754
Liu Z [Effects of acupuncture on lipid, TXB2, 6-keto-PGF, alpha in simple obese patients complicated with hyperlipidemia]. 1996 Zhen Ci Yan Jiu pmid:9388312
Li T et al. [Observation on TXB2 and 6-keto-PGF1 alpha in serum of patients with cor pulmonale]. 1996 Hua Xi Yi Ke Da Xue Xue Bao pmid:9389073
Bellamy MC et al. Changes in inflammatory mediators during orthotopic liver transplantation. 1997 Br J Anaesth pmid:9389852
Wettstein M and Häussinger D Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. 1997 Hepatology pmid:9397998
Knowles SO and Donaldson WE Lead disrupts eicosanoid metabolism, macrophage function, and disease resistance in birds. 1997 Oct-Nov Biol Trace Elem Res pmid:9404672
Vezza R et al. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. 1997 Thromb. Haemost. pmid:9408024
Byrne A et al. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9409315
Davi G et al. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9409316
Gerdemann R et al. [Effect of flunixin meglumine on plasma prostanoid concentrations in horses with colic in the perioperative period]. 1997 DTW. Dtsch. Tierarztl. Wochenschr. pmid:9410724
Davì G et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. 1997 Am. J. Respir. Crit. Care Med. pmid:9412557
Alanko J et al. Catechol estrogens as inhibitors of leukotriene synthesis. 1998 Biochem. Pharmacol. pmid:9413936
Oosaki R et al. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. 1997 Int. Arch. Allergy Immunol. pmid:9414142
Moutquin JM et al. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study. 1997 Am. J. Obstet. Gynecol. pmid:9423755
Gresele P et al. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests. 1997 Thromb. Haemost. pmid:9423790
Famaey JP In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. 1997 Inflamm. Res. pmid:9427063
Akarsu ES et al. Effect of ciliary neurotrophic factor on body temperature and cerebrospinal fluid prostanoids in the cat. 1998 Brain Res. Bull. pmid:9434196
Qureshi MA and Gore AB Vitamin E exposure modulates prostaglandin and thromboxane production by avian cells of the mononuclear phagocytic system. 1997 Immunopharmacol Immunotoxicol pmid:9436047
Sheu JR et al. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9437193
Sorem KA and Siler-Khodr TM Effect of IGF-I on placental thromboxane and prostacyclin release in severe intrauterine growth retardation. 1997 Nov-Dec J Matern Fetal Med pmid:9438218
Kurosawa M et al. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. 1997 J. Allergy Clin. Immunol. pmid:9440541